GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Cyclically Adjusted PB Ratio

Abaxis (Abaxis) Cyclically Adjusted PB Ratio : (As of May. 06, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abaxis Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Abaxis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Cyclically Adjusted PB Ratio Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abaxis's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Abaxis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abaxis's Cyclically Adjusted PB Ratio falls into.



Abaxis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abaxis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2018 is calculated as:

For example, Abaxis's adjusted Book Value per Share data for the three months ended in Mar. 2018 was:

Adj_Book=Book Value per Share/CPI of Mar. 2018 (Change)*Current CPI (Mar. 2018)
=12.807/105.2895*105.2895
=12.807

Current CPI (Mar. 2018) = 105.2895.

Abaxis Quarterly Data

Book Value per Share CPI Adj_Book
200806 5.038 92.320 5.746
200809 5.311 92.307 6.058
200812 5.578 88.697 6.621
200903 5.794 89.744 6.798
200906 5.971 91.003 6.908
200909 6.179 91.120 7.140
200912 6.426 91.111 7.426
201003 6.653 91.821 7.629
201006 6.776 91.962 7.758
201009 6.966 92.162 7.958
201012 7.237 92.474 8.240
201103 7.467 94.283 8.339
201106 7.510 95.235 8.303
201109 6.854 95.727 7.539
201112 7.079 95.213 7.828
201203 7.364 96.783 8.011
201206 7.514 96.819 8.171
201209 8.160 97.633 8.800
201212 7.524 96.871 8.178
201303 7.965 98.209 8.539
201306 8.051 98.518 8.604
201309 8.275 98.790 8.819
201312 8.389 98.326 8.983
201403 8.693 99.695 9.181
201406 8.768 100.560 9.180
201409 8.972 100.428 9.406
201412 9.246 99.070 9.826
201503 9.769 99.621 10.325
201506 9.913 100.684 10.366
201509 10.236 100.392 10.735
201512 10.565 99.792 11.147
201603 10.546 100.470 11.052
201606 10.763 101.688 11.144
201609 11.234 101.861 11.612
201612 11.499 101.863 11.886
201703 11.811 102.862 12.090
201706 11.969 103.349 12.194
201709 12.211 104.136 12.346
201712 12.383 104.011 12.535
201803 12.807 105.290 12.807

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abaxis  (NAS:ABAX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abaxis Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Abaxis's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020